More than 70% of newly diagnosed bladder cancers belong to NMIBC, which is characterized morphologically by frequent papillary structures, and genetically by deletion of chromosome 9 and point mutation of fibroblast growth factor receptor 3 (FGFR3). This evidence concerns the gene FGFR3 and urinary bladder cancer.